Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Lavage vs Bolus Surfactant in MAS
NCT02041546Phase 4Completed
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Poractant alfa in Meconium aspiration syndrome (MAS) (2 arms), sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital. Primary endpoint: Duration of mechanical ventilation up to 2 weeks. Started Sep 2013; status: completed.
02
Drugs
Poractant alfa
03
Conditions
Meconium aspiration syndrome (MAS)
Beyond the preview
Go deeper on NCT02041546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041546.